|
Caged compounds
Since the invention of the microscope by Robert
Hooke in 1695, light has been to study cells.
Most laboratories are satisfied with such passive observation,
however we use not only to observe but also to
stimulate cellular chemistry. This area of biophotonics
is called “caged compounds” as synthetic
organic chemistry is used to make biologically
signaling molecules functionally inert; irradiation
liberates the caged molecules, thus “switching
on” a chosen signaling pathway.
We have developed many caged compounds for
stimulating both intracellular and extracellular
receptors. These molecules include caged calcium,
IP3, glutamate, GABA, D-apartate, serotonin,
dopamine, anisomycin, siphigosine, capsacin,
nitric oxide, carbamoylcholine, BAPTA, etc.
Caged calcium
Calcium is the most important signaling molecule
inside cells. Fluctuations in its concentration
control gene transcription, insulin secretion,
muscle contraction, neurotransmission, wound
healing, etc.
The laboratory has developed four useful calcium cages: DM-nitrophen; NP-EGTA;
DMNPE-4 and NDBF-EGTA. Two of our calcium cages (DM-nitrophen and NP-EGTA) have
been commercially available for some time now. So, literally hundreds of biological
studies have been published by us and many other groups using these probes. In
particular, Erwin Neher and Bob Zucker and their co-workers have used our cages
to study secretion in many cells (they have published more than 60 caged calcium
papers).

Recently we have developed a new caging chromophore
(NDBF) that is much more efficient than the traditional
nitrobenzyl one that has so widely used by many
groups for the past 20 years. Our first application
of this new chromophore has been to caged Ca
(NDBF-EGTA). The table summarizes the two basic
of physico-chemical properties of all the commercially
available nitrobenzyl-caged compounds: the extinction
coefficient ( ε ) and the quantum yield ( φ ).
The product ( ε.φ ) is the measure of the efficiency
of uncaging. (Significantly, the 2-photon cross
section of NDBF-EGTA is also very high, being
about 0.6 GM.)
Caged neurotransmitters
Glutamate is the major transmitter in the CNS,
being responsible for about 80% of transmission.
In 2000 we synthesized MNI-glutamate; the Mill
Hill group, lead by John Corrie, independently
made the same compound. We, however, were the
first to use this molecule for 2-photon photolysis
in brain slices, in collaboration Haruo Kasai.
Recently we have made a new caged glutamate (MDNI-glu)
that is 10 times better than MNI-glu. The table
summarizes the properties of all the caged glutamates
that have been made by various groups over the
past 10 years
Chromophore |
Φ |
2-photon
cross section (GM) |
ε (
350 nm)
|
Φ.ε |
MDNI |
0.47 |
0.06 |
8,600 |
4042 |
MNI |
0.085 |
0.06 |
4,300 |
366 |
NI |
0.043 |
No datum |
2,700 |
116 |
Bhc |
0.019 |
0.95 |
17,300 |
329 |
CNB |
0.15 |
<0.001 |
500 |
75 |
pHP |
0.08 |
No datum |
200 |
16 |
New caged compounds
Our current efforts focus on two fronts: synthesis
of of photochromic calcium chelators (moleculs
we call “calcium switches”); and
the development of caged compounds for in
vivo 2-photon photolysis. The lab uses 2-photon
microscopy to study calcium signaling in vivo.
Rapid drug application is impractical is such
circumstances, thus we will synthesize pro-drugs
that are caged and can be loaded into the brain
of the living animal, and uncaged using the dual
2P microscope, during calcium imaging.
|